Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Disease Reports
fungal eye infections
MeSH D015821 - fungal eye infections
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D015817:
Eye infections
0 Companies
0 Drugs
Success rate
D009181:
Mycoses
144 Companies
35 Drugs
$
Success rate
D015821:
Fungal eye infections
1 Company
1 Drug
$
Success rate
D015829:
Suppurative uveitis
0 Companies
0 Drugs
Success rate
Events Timeline
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
Harrow
Natamycin
Natacyn
1982-01-01
Clinical Trials
Historical Success Rate
Phase 1
0
%
0/0
Phase 2
0
%
0/0
Phase 3
67
%
2/3
Approved:
1
Overall Success rate:
0%
All Clinical Trials
No data
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use